We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Karzinom unklaren Ursprungs – interdisziplinäre Therapiestruktur

    Background

    Cancer of unknown primary (CUP) still represents a diagnostic and therapeutic challenge. The prognosis of CUP is poor in most cases,...

    Boris Kubuschok, Rainer Claus, Michael Stahl in Die Onkologie
    Article 21 February 2024
  2. Adenoid-zystisches Karzinom der Zeruminaldrüsen

    Stephanie Strobl, Matthias M. Gaida in Die Pathologie
    Article 19 February 2024
  3. Verhindert die Fundoplicatio das Barrett-Karzinom?

    Constanze H. Waggershauser in Gastro-News
    Article 17 April 2024
  4. Kolorektales Karzinom

    Being one of the most common tumor entities worldwide, the colorectal carcinoma accounts for approximately 10% of all tumor-related deaths. With...

    Cheng Zhang, Margarete Stampfl-Mattersberger, ... Christian Sebesta in Wiener Medizinische Wochenschrift
    Article 08 November 2022
  5. Hepatozelluläres Karzinom

    The therapeutic spectrum of hepatocellular carcinoma (HCC) in cirrhosis has expanded over the last decade and consists of surgical, interventional...

    Felix Braun, Jost Philipp Schäfer, ... Michael Linecker in best practice onkologie
    Article 02 February 2023
  6. Multiparametrische MRT-Bildgebung beim hepatozellulären Karzinom, Teil 1

    Radiology plays a key role in the diagnosis and monitoring of hepatocellular carcinoma (HCC). Ultrasound, computed tomography (CT) and magnetic...

    Mona Jahn, Günter Layer in Die Radiologie
    Article 19 March 2024
  7. Metastasiertes kolorektales Karzinom – moderne Therapiestrategien und -sequenzen

    The treatment of metastatic colorectal cancer (mCRC) has been considerably expanded and relevantly improved in recent years with new strategies, such...

    T. J. Ettrich, J. S. Schuhbaur, Thomas Seufferlein in Die Onkologie
    Article 30 January 2024
  8. Aktuelle systemische Therapie beim cholangiozellulären Karzinom

    Cholangiocarcinoma (CCA) is a rare cancer, accounting for approximately 15% of all primary liver tumors and 3% of gastrointestinal malignancies....

    Andreas W. Berger, Lukas Perkhofer, Thomas J. Ettrich in Die Onkologie
    Article 23 June 2023
  9. Therapierefraktäres kolorektales Karzinom mit KRAS-G12C-Mutation

    Milan J. M. Hartmann, Hakan Alakus in Die Onkologie
    Article 19 April 2024
  10. Hereditäres kolorektales Karzinom

    Background

    Approximately 5% of patients with colorectal carcinoma (CRC) have a monogenic hereditary tumor syndrome. These include Lynch syndrome and...

    Isabel Spier, Stefan Aretz in coloproctology
    Article 01 March 2024
  11. Multiparametrische MRT-Bildgebung beim hepatozellulären Karzinom, Teil 2

    In addition to morphology and tissue perfusion, diffusion-weighted imaging (DWI) is the third pillar of multiparametric diagnostics in oncology. Due...

    Mona Jahn, Günter Layer in Die Radiologie
    Article 17 June 2024
  12. Tumor-Immunzell-Interaktion und Seneszenz-assoziierte Moleküle im kolorektalen Karzinom

    Background

    Cellular senescence permanently arrests the cell cycle of premalignant cells following protumorigenic stimuli, counteracting tumor...

    Franziska Kellers in Die Pathologie
    Article 01 December 2023
  13. Metastasiertes kolorektales Karzinom – moderne Therapiestrategien und -sequenzen

    The treatment of metastatic colorectal cancer (mCRC) has been considerably expanded and relevantly improved in recent years with new strategies, such...

    T. J. Ettrich, J. S. Schuhbaur, T. Seufferlein in Die Innere Medizin
    Article 24 May 2023
  14. Hepatozelluläres Karzinom

    The therapeutic spectrum of hepatocellular carcinoma (HCC) in cirrhosis has expanded over the last decade and consists of surgical, interventional...

    Felix Braun, Jost Philipp Schäfer, ... Michael Linecker in Die Chirurgie
    Article 17 June 2022
  15. Checkpointinhibitoren beim kolorektalen Karzinom – eine neue Ära?

    Background

    Checkpoint-inhibitors have shown high response rates in some tumours such as melanomas.

    Objectives

    This article describes the data...

    Christian Pox in Die Innere Medizin
    Article 11 April 2023
  16. Multistain Deep Learning zur Vorhersage von Prognose und Therapieansprechen im kolorektalen Karzinom

    The tumor immune microenvironment (TIME) plays a crucial prognostic and predictive role in solid malignancies such as colorectal cancer (CRC)....

    Stefan Schulz, Moritz Jesinghaus, Sebastian Foersch in Die Pathologie
    Article 21 November 2023
Did you find what you were looking for? Share feedback.